Not Yet Recruiting
Familial B-cell Lymphoproliferative Disorders
NCT05718986
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
- Locations
-
Not specified
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
144 public trials
33 recruiting studies
Lymphoproliferative Disorders trial results
NCT02393859
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Research Site Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- Research Site Randwick, New South Wales, Australia
- Research Site Westmead, New South Wales, Australia
- Research Site South Brisbane, Queensland, Australia
NCT05415137
- Conditions
- Fibrosis, Granuloma, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- aTyr Investigative Site Birmingham, Alabama, United States
- aTyr Investigative Site Phoenix, Arizona, United States
- aTyr Investigative Site Los Angeles, California, United States
- aTyr Investigative Site Sacramento, California, United States
NCT03349450
- Conditions
- Adult Diffuse Large Cell Lymphoma, Adult Refractory Diffuse Large B-Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +18 more
- Locations
-
- Tom Baker Cancer Centre - Alberta Health Services Calgary, Alberta, Canada
- Nova Scotia Health Authority: Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada
- London Health Sciences Centre London, Ontario, Canada
- Ottawa Hospital Research Institute Ottawa, Ontario, Canada
NCT05804032
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Universitätsklinikum Krems Krems, Austria
- Ordensklinikum Linz Linz, Austria
- Landeskrankenhaus Feldkirch-Rankweil Rankweil, Austria
- Universitätsklinikum der Paracelsus, 3. Med. Abteilung/Onkologie Ambulanz Salzburg, Austria
NCT00033475
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +3 more
- Locations
-
- Birmingham Children's Hospital Birmingham, England, United Kingdom
- Papworth Hospital Cambridge, England, United Kingdom
- Royal Free and University College Medical School London, England, United Kingdom
- King's College Hospital London, England, United Kingdom
Completed
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
NCT05228470
- Conditions
- BCMA, BCMA-CD3 Bispecific, Bispecific, +23 more
- Locations
-
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT00001379
- Conditions
- DNA Virus Infections, Epstein-Barr Virus Infections, Granulomatosis, Lymphomatoid, +18 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT03397706
- Conditions
- Epstein-Barr Virus-Associated Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +3 more
- Locations
-
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California, Los Angeles Los Angeles, California, United States
- UC Irvine Chao Family Comprehensive Cancer Center Orange, California, United States
- University of Colorado Anschutz Cancer Pavilion Aurora, Colorado, United States
NCT01186224
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Dept of Haematology, University of Liverpool Liverpool, Merseyside, United Kingdom